Heet Healthcare Private Limited — Rituximab Exporter Profile
Indian Pharmaceutical Exporter · #13 for Rituximab · $58.3K export value · DGFT Verified
Heet Healthcare Private Limited is the #13 Indian exporter of Rituximab with $58.3K in export value and 10 verified shipments. Heet Healthcare Private Limited holds a 0.3% market share in Rituximab exports across 3 countries. The company exports 11 pharmaceutical products worth $867.1K across 2 therapeutic categories.
Heet Healthcare Private Limited — Rituximab Export Profile: Buyers & Destinations
Where Does Heet Healthcare Private Limited Export Rituximab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| POLAND | $56.4K | 7 | 96.8% |
| UNITED ARAB EMIRATES | $1.6K | 1 | 2.7% |
| KAZAKISTAN | $160 | 1 | 0.3% |
| KAZAKHSTAN | $157 | 1 | 0.3% |
Heet Healthcare Private Limited exports Rituximab to 4 countries. The largest destination is POLAND accounting for 96.8% of Heet Healthcare Private Limited's Rituximab shipments, followed by UNITED ARAB EMIRATES (2.7%) and KAZAKISTAN (0.3%). These destinations reflect Heet Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rituximab from Heet Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNIVERSUM BCL SP. Z O.O. | POLAND | $43.7K | 5 |
| UNIVERSUM BCL SP Z O O | POLAND | $6.7K | 1 |
| UNIVERSUM BCL SP ZOO UL LWOWSKA | POLAND | $6.0K | 1 |
| MASTER LOGISICS FZCO | UNITED ARAB EMIRATES | $1.6K | 1 |
| KARABEKOVA RAIHAAN | KAZAKISTAN | $160 | 1 |
| KARABEKOVA RAIHAN | KAZAKHSTAN | $157 | 1 |
Heet Healthcare Private Limited supplies Rituximab to 6 buyers globally. The largest buyer is UNIVERSUM BCL SP. Z O.O. (POLAND), followed by UNIVERSUM BCL SP Z O O (POLAND) and UNIVERSUM BCL SP ZOO UL LWOWSKA (POLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rituximab Export Value and How Much Does Heet Healthcare Private Limited Contribute?
India exported $9.4M worth of Rituximab through 1,215 shipments from 164 suppliers to 104 countries, serving 292 buyers globally. Heet Healthcare Private Limited contributes $58.3K to this total, accounting for 0.3% of India's Rituximab exports. Heet Healthcare Private Limited ships Rituximab to 4 countries through 6 buyers.
What Is the Average Shipment Value for Heet Healthcare Private Limited's Rituximab Exports?
Heet Healthcare Private Limited's average Rituximab shipment value is $5.8K per consignment, based on 10 shipments totaling $58.3K. The largest destination is POLAND (96.8% of Heet Healthcare Private Limited's Rituximab exports).
How Does Heet Healthcare Private Limited Compare to Other Indian Rituximab Exporters?
Heet Healthcare Private Limited ranks #13 among 164 Indian Rituximab exporters with a 0.3% market share. The top 3 exporters are RELIANCE LIFE SCIENCES PRIVATE LIMITED ($4.1M), DR.REDDY'S LABORATORIES LTD ($3.2M), DR REDDYS LABORATORIES LIMITED ($550.0K). Heet Healthcare Private Limited processed 10 shipments to 3 destination countries.
What Rituximab Formulations Does Heet Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| (PHARMA ITEM) Reditux 500mg Rituximab 50 | $12.8K | 1 |
| (PHARMA ITEM) RITUXIMAB 500MG INJECTION-RITUXIMAB 500MG INJECTIONNOS | $12.5K | 1 |
| PHARMA ITEMRituximab 500mg Injection-R | $6.7K | 1 |
| (PHARMA ITEM) RITUXIMAB 500MG INJECTION RITUXIMAB 500MG INJECTION(OTHER DETAILS AS PER INV) | $6.5K | 1 |
| (PHARMA ITEM)RITUXIMAB 500MG INJECTION -RITUXIMAB 500MG INJECTION (OTHER DETAILS AS PER INV) | $6.0K | 1 |
| PHARMA ITEM Rituximab 500mg Injection-Rituximab 500mg Injection | $6.0K | 1 |
| (PHARMA ITEM) RITUXIMAB 500MG INJECTION-RITUXIMAB 500MG INJECTION | $6.0K | 1 |
| (PHARMA ITEM) RITUXIREL 500 - RITUXIMAB500MG(OTHER DETAILS AS PER INV) | $1.6K | 1 |
| PHARMACUTICAL PRODUCTS :RITUXIMAB (500MG) BARCH NO RB2353APCS | $160 | 1 |
| PHARMACUTICAL;Rituximab 500mg Batch : | $157 | 1 |
Heet Healthcare Private Limited exports 10 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is (PHARMA ITEM) Reditux 500mg Rituximab 50 with 1 shipments worth $12.8K.
How Does Heet Healthcare Private Limited Compare to Nearest Rituximab Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | PNT PHARMA | $86.7K | 12 | 1 | $7.2K |
| 12 | SANSKRUTI PHARMA | $71.6K | 62 | 3 | $1.2K |
| 13 | HEET HEALTHCARE PRIVATE LIMITED ★ | $58.3K | 10 | 3 | $5.8K |
| 14 | DOSHI MEDICARE PRIVATE LIMITED | $55.6K | 14 | 5 | $4.0K |
Heet Healthcare Private Limited ranks #13 among 164 Indian Rituximab exporters. Average shipment value of $5.8K compared to the market average of $57.4K. The closest competitors by value are PNT PHARMA and SANSKRUTI PHARMA.
Which Indian Ports Ship Rituximab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 389 | 32.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 325 | 26.7% |
| Bombay Air | 85 | 7.0% |
| Bombay Air Cargo | 58 | 4.8% |
| HYDERABAD ACC (INHYD4) | 46 | 3.8% |
| DELHI AIR CARGO ACC (INDEL4) | 45 | 3.7% |
| DELHI AIR | 35 | 2.9% |
| AHEMDABAD AIR | 26 | 2.1% |
What Other Advanced Oncology Products Does Heet Healthcare Private Limited Export?
Heet Healthcare Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Heet Healthcare Private Limited
Heet Healthcare Private Limited exports 11 products worth $867.1K. Beyond Rituximab, top products include Sofosbuvir, Velpatasvir, Sorafenib, Lenvatinib, Pazopanib. View the complete Heet Healthcare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rituximab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Heet Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 10 individual customs records matching Heet Healthcare Private Limited exporting Rituximab, covering 10 formulations to 4 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 292+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rituximab Export Data from Heet Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Heet Healthcare Private Limited's Rituximab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Heet Healthcare Private Limited
Full Company Profile →
11 products · $867.1K total trade · 2 categories
Rituximab Stats
Company Overview
Top Products by Heet Healthcare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Heet Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rituximab. For current shipment-level data, contact TransData Nexus.